Skip to main content
Erschienen in: Immunologic Research 2/2021

30.03.2021 | Original Article

Potential role of viral infection and B cells as a linker between innate and adaptive immune response in systemic lupus erythematosus

verfasst von: Mohadeseh Zarei Ghobadi, Shima Izadi, Majid Teymoori-Rad, Mohammad Farahmand, Sayed-Hamidreza Mozhgani, Negar Labbaf, Fazel Shokri, Sayed Mahdi Marashi

Erschienen in: Immunologic Research | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease that involves several organ systems. Although B cells play a key role in SLE pathogenesis, the mechanisms behind B cell dysregulation in SLE development remained controversial. Finding the modules containing highly co-expressed genes in B cells could explain biological pathways involved in the pathogenesis of SLE, which may further support the reasons for the altered function of B cells in SLE disease. A total of three microarray gene expression datasets were downloaded from Gene Expression Omnibus. SLE samples were prepared from the purified B lymphocyte cells of the patients who have not received immunosuppressive drugs as well as high dose immunocytotoxic therapies or steroids. A weighted gene co-expression network was then constructed to find the relevant modules implicated in the SLE progression. Among 17 identified modules, 3 modules were selected through mapping to STRING and finding the ones that had highly connection at the protein level. These modules clearly indicate the involvement of several pathways in the pathogenesis of SLE including viral infection, adaptive immune response, and innate immune response in B lymphocytes. The WGCN analysis further revealed the co-expressed genes involved in both innate and adaptive immune systems. Mix infections and primary immunodeficiency might also dysregulate B lymphocytes, which may facilitate SLE development. As such, identifying novel biomarkers and pathways in lupus would be of importance.
Literatur
1.
Zurück zum Zitat Jakes RW, Bae SC, Louthrenoo W, Mok CC, Navarra SV, Kwon N. Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality. Arthritis Care Res. 2012;64(2):159–68.CrossRef Jakes RW, Bae SC, Louthrenoo W, Mok CC, Navarra SV, Kwon N. Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality. Arthritis Care Res. 2012;64(2):159–68.CrossRef
3.
Zurück zum Zitat Maidhof W, Hilas O. Lupus: an overview of the disease and management options. Pharm Ther. 2012;37(4):240. Maidhof W, Hilas O. Lupus: an overview of the disease and management options. Pharm Ther. 2012;37(4):240.
4.
Zurück zum Zitat Pan L, Lu M-P, Wang J-H, Xu M, Yang S-R. Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr. 2020;16(1):19–30. Pan L, Lu M-P, Wang J-H, Xu M, Yang S-R. Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr. 2020;16(1):19–30.
5.
Zurück zum Zitat Shlomchik MJ. Sites and stages of autoreactive B cell activation and regulation. Immunity. 2008;28(1):18–28.CrossRef Shlomchik MJ. Sites and stages of autoreactive B cell activation and regulation. Immunity. 2008;28(1):18–28.CrossRef
6.
Zurück zum Zitat Lund FE. Cytokine-producing B lymphocytes—key regulators of immunity. Curr Opin Immunol. 2008;20(3):332–8.CrossRef Lund FE. Cytokine-producing B lymphocytes—key regulators of immunity. Curr Opin Immunol. 2008;20(3):332–8.CrossRef
7.
Zurück zum Zitat Hampe CS. B cells in autoimmune diseases. Scientifica. 2012;2012:215308. Hampe CS. B cells in autoimmune diseases. Scientifica. 2012;2012:215308.
8.
Zurück zum Zitat Harvey PR, Gordon C. B-cell targeted therapies in systemic lupus erythematosus. BioDrugs. 2013;27(2):85–95.CrossRef Harvey PR, Gordon C. B-cell targeted therapies in systemic lupus erythematosus. BioDrugs. 2013;27(2):85–95.CrossRef
9.
Zurück zum Zitat Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Seminars in arthritis and rheumatism. 2004; 34(2):501–37. Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Seminars in arthritis and rheumatism. 2004; 34(2):501–37.
10.
Zurück zum Zitat Dema B, Charles N. Autoantibodies in SLE: specificities, isotypes and receptors. Antibodies. 2016;5(1):2.CrossRef Dema B, Charles N. Autoantibodies in SLE: specificities, isotypes and receptors. Antibodies. 2016;5(1):2.CrossRef
11.
Zurück zum Zitat Thurman JM, Yapa R. Complement therapeutics in autoimmune disease. Front Immunol. 2019;10:672. Thurman JM, Yapa R. Complement therapeutics in autoimmune disease. Front Immunol. 2019;10:672.
12.
Zurück zum Zitat Yurasov S, Tiller T, Tsuiji M, Velinzon K, Pascual V, Wardemann H, et al. Persistent expression of autoantibodies in SLE patients in remission. J Exp Med. 2006;203(10):2255–61.CrossRef Yurasov S, Tiller T, Tsuiji M, Velinzon K, Pascual V, Wardemann H, et al. Persistent expression of autoantibodies in SLE patients in remission. J Exp Med. 2006;203(10):2255–61.CrossRef
15.
Zurück zum Zitat Holtman IR, Raj DD, Miller JA, Schaafsma W, Yin Z, Brouwer N, et al. Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis. Acta Neuropathol Commun. 2015;3(1):31.CrossRef Holtman IR, Raj DD, Miller JA, Schaafsma W, Yin Z, Brouwer N, et al. Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis. Acta Neuropathol Commun. 2015;3(1):31.CrossRef
16.
Zurück zum Zitat Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9(1):559.CrossRef Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9(1):559.CrossRef
17.
Zurück zum Zitat Giulietti M, Occhipinti G, Principato G, Piva F. Weighted gene co-expression network analysis reveals key genes involved in pancreatic ductal adenocarcinoma development. Cell Oncol. 2016;39(4):379–88.CrossRef Giulietti M, Occhipinti G, Principato G, Piva F. Weighted gene co-expression network analysis reveals key genes involved in pancreatic ductal adenocarcinoma development. Cell Oncol. 2016;39(4):379–88.CrossRef
18.
Zurück zum Zitat Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2018;47(D1):D607–13.CrossRef Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2018;47(D1):D607–13.CrossRef
19.
Zurück zum Zitat Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, et al. STRING v10: protein–protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2014;43(D1):D447–52.CrossRef Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, et al. STRING v10: protein–protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2014;43(D1):D447–52.CrossRef
20.
Zurück zum Zitat Bastian M, Heymann S, Jacomy M. Gephi: an open source software for exploring and manipulating networks. Third international AAAI conference on weblogs and social media2009. Bastian M, Heymann S, Jacomy M. Gephi: an open source software for exploring and manipulating networks. Third international AAAI conference on weblogs and social media2009.
21.
Zurück zum Zitat Reimand J, Arak T, Adler P, Kolberg L, Reisberg S, Peterson H, et al. g: Profiler—a web server for functional interpretation of gene lists (2016 update). Nucleic Acids Res. 2016;44(W1):W83–9.CrossRef Reimand J, Arak T, Adler P, Kolberg L, Reisberg S, Peterson H, et al. g: Profiler—a web server for functional interpretation of gene lists (2016 update). Nucleic Acids Res. 2016;44(W1):W83–9.CrossRef
27.
Zurück zum Zitat McChesney MB, Kehrl JH, Valsamakis A, Fauci AS, Oldstone MB. Measles virus infection of B lymphocytes permits cellular activation but blocks progression through the cell cycle. J Virol. 1987;61(11):3441–7.CrossRef McChesney MB, Kehrl JH, Valsamakis A, Fauci AS, Oldstone MB. Measles virus infection of B lymphocytes permits cellular activation but blocks progression through the cell cycle. J Virol. 1987;61(11):3441–7.CrossRef
28.
Zurück zum Zitat Zhdanov V. Integration of viral genomes. Nature. 1975;256(5517):471–3.CrossRef Zhdanov V. Integration of viral genomes. Nature. 1975;256(5517):471–3.CrossRef
33.
Zurück zum Zitat Chen L, Widhopf G, Huynh L, Rassenti L, Rai KR, Weiss A, et al. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia. Blood. 2002;100(13):4609–14.CrossRef Chen L, Widhopf G, Huynh L, Rassenti L, Rai KR, Weiss A, et al. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia. Blood. 2002;100(13):4609–14.CrossRef
34.
Zurück zum Zitat Chen L, Apgar J, Huynh L, Dicker F, Giago-McGahan T, Rassenti L, et al. ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia. Blood. 2005;105(5):2036–41.CrossRef Chen L, Apgar J, Huynh L, Dicker F, Giago-McGahan T, Rassenti L, et al. ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia. Blood. 2005;105(5):2036–41.CrossRef
36.
Zurück zum Zitat Majolini MB, D’elios MM, Galieni P, Boncristiano M, Lauria F, Del Prete G, et al. Expression of the T-cell–specific tyrosine kinase Lck in normal B-1 cells and in chronic lymphocytic leukemia B cells. Blood. 1998;91(9):3390–6.CrossRef Majolini MB, D’elios MM, Galieni P, Boncristiano M, Lauria F, Del Prete G, et al. Expression of the T-cell–specific tyrosine kinase Lck in normal B-1 cells and in chronic lymphocytic leukemia B cells. Blood. 1998;91(9):3390–6.CrossRef
37.
Zurück zum Zitat Isaák A, Gergely P Jr, Szekeres Z, Prechl J, Poór G, Erdei A, et al. Physiological up-regulation of inhibitory receptors FcγRII and CR1 on memory B cells is lacking in SLE patients. Int Immunol. 2008;20(2):185–92.CrossRef Isaák A, Gergely P Jr, Szekeres Z, Prechl J, Poór G, Erdei A, et al. Physiological up-regulation of inhibitory receptors FcγRII and CR1 on memory B cells is lacking in SLE patients. Int Immunol. 2008;20(2):185–92.CrossRef
40.
Zurück zum Zitat Feng X, Wu H, Grossman JM, Hanvivadhanakul P, FitzGerald JD, Park GS, et al. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Arthritis Rheum. 2006;54(9):2951–62. https://doi.org/10.1002/art.22044.CrossRefPubMed Feng X, Wu H, Grossman JM, Hanvivadhanakul P, FitzGerald JD, Park GS, et al. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Arthritis Rheum. 2006;54(9):2951–62. https://​doi.​org/​10.​1002/​art.​22044.CrossRefPubMed
45.
Zurück zum Zitat Hamilton JA, Hsu HC, Mountz JD. Role of production of type I interferons by B cells in the mechanisms and pathogenesis of systemic lupus erythematosus. Discov Med. 2018;25(135):21–9.PubMed Hamilton JA, Hsu HC, Mountz JD. Role of production of type I interferons by B cells in the mechanisms and pathogenesis of systemic lupus erythematosus. Discov Med. 2018;25(135):21–9.PubMed
50.
Zurück zum Zitat Duhlin A. The regulation of B cell responses in systemic autoimmunity. Thesis, 2017 Duhlin A. The regulation of B cell responses in systemic autoimmunity. Thesis, 2017
51.
Zurück zum Zitat McGaha TL, Sorrentino B, Ravetch JV. Restoration of tolerance in lupus by targeted inhibitory receptor expression. Science. 2005;307(5709):590–3.CrossRef McGaha TL, Sorrentino B, Ravetch JV. Restoration of tolerance in lupus by targeted inhibitory receptor expression. Science. 2005;307(5709):590–3.CrossRef
52.
Zurück zum Zitat Kyogoku C, Dijstelbloem HM, Tsuchiya N, Hatta Y, Kato H, Yamaguchi A, et al. Fcγ receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility. Arthritis Rheum. 2002;46(5):1242–54.CrossRef Kyogoku C, Dijstelbloem HM, Tsuchiya N, Hatta Y, Kato H, Yamaguchi A, et al. Fcγ receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility. Arthritis Rheum. 2002;46(5):1242–54.CrossRef
53.
Zurück zum Zitat Mkaddem SB, Murua A, Flament H, Titeca-Beauport D, Bounaix C, Danelli L, et al. Lyn and Fyn function as molecular switches that control immunoreceptors to direct homeostasis or inflammation. Nat Commun. 2017;8(1):1–13.CrossRef Mkaddem SB, Murua A, Flament H, Titeca-Beauport D, Bounaix C, Danelli L, et al. Lyn and Fyn function as molecular switches that control immunoreceptors to direct homeostasis or inflammation. Nat Commun. 2017;8(1):1–13.CrossRef
62.
Zurück zum Zitat Harvey BP, Gee RJ, Haberman AM, Shlomchik MJ, Mamula MJ. Antigen presentation and transfer between B cells and macrophages. Eur J Immunol. 2007;37(7):1739–51.CrossRef Harvey BP, Gee RJ, Haberman AM, Shlomchik MJ, Mamula MJ. Antigen presentation and transfer between B cells and macrophages. Eur J Immunol. 2007;37(7):1739–51.CrossRef
Metadaten
Titel
Potential role of viral infection and B cells as a linker between innate and adaptive immune response in systemic lupus erythematosus
verfasst von
Mohadeseh Zarei Ghobadi
Shima Izadi
Majid Teymoori-Rad
Mohammad Farahmand
Sayed-Hamidreza Mozhgani
Negar Labbaf
Fazel Shokri
Sayed Mahdi Marashi
Publikationsdatum
30.03.2021
Verlag
Springer US
Erschienen in
Immunologic Research / Ausgabe 2/2021
Print ISSN: 0257-277X
Elektronische ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-021-09186-4

Weitere Artikel der Ausgabe 2/2021

Immunologic Research 2/2021 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.